Quantified Evaluation of Noninvasive System Delivering Microwave Energy for Unwanted Fat Reduction and Skin Tightening in Asians.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

15 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-31

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to evaluate the effectiveness and safety of microwave-assisted heating technology in facial fat reduction and skin tightening in Asians.

The main questions it aims to answer are:

1. How effective is the microwave-based system in reducing fat and tightening Skin?
2. What objective methods can be used to measure treatment outcomes?
3. What are the optimal treatment parameters for maximum efficacy?
4. What are the safety and side effects associated with the treatment?
5. How long-lasting are the results?

Participants will go through three treatment sessions using the "DEKA" ONDA Microwave treatment system, with each session lasting 12 minutes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Facial Contouring With Monopolar RF and Continuous Water Cooling

NCT07317089

Skin Aging Sagging Skin Laxity; Skin

COMPLETED NA

Quantitative Evaluation of Skin Shrinkage Caused by a Non-invasive Tightening Device

NCT00894244

Healthy

COMPLETED NA

Evaluating the Long-term Effects of Microfocused Ultrasound on Facial Tightening Using Quantitative Instruments

NCT06286384

Facial Aging

COMPLETED

Efficacy of Long Pulsed 1064nm Laser for Facial Skin Tightening

NCT01971736

Skin Tightening Skin Laxity Wrinkle Reduction

COMPLETED

Fractional Co2 Laser Versus Microbotox Injection in the Treatment of Wide Facial Pores: A Split Face Comparative Study

NCT05923996

Skin Abnormalities

NOT_YET_RECRUITING PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

As people age, facial skin sagging and submental fat accumulation have become concerns for many, not only affecting their appearance but also negatively impacting their self-confidence. With the continuous advancement of modern medical aesthetic technology, noninvasive treatments like microwave-assisted heating technology have provided new solutions for addressing these issues.

The microwave-assisted heating technology works by precisely heating subcutaneous fat tissue with high-frequency energy, inducing fat cell apoptosis while simultaneously stimulating collagen production in the skin, thereby achieving fat reduction and skin tightening. Compared to traditional surgical methods, this technique offers the advantages of being non-invasive, having a short recovery period, and carrying lower risks.

To further investigate these effects, we plan to conduct a prospective, open-label clinical trial. The treatment will focus on enhancing the mid and lower facial area, while carefully managing the treatment time and monitoring patient comfort.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Facial Aging Skin Laxity Cheek Wrinkles

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women aged between 20 and 60.
* Subjects who are capable of understanding and comply with the study procedures, instructions, and visit schedule.
* Subjects who voluntarily decide to participate in the entire course of the trial and provide written consent in the Informed Consent Form.

Exclusion Criteria

* Subjects with autoimmune diseases/received immunotherapy and subjects with diabetes mellitus.
* Subjects with a history of a hypertrophic scar.
* Pregnant or breastfeeding women.
* Subjects with untreated epilepsy or underlying porphyria.
* When there is an active disease (such as inflammation, infection or tumors) in or near the intended treatment site.
* Treatment procedure (e.g., bioresorbable fillers, laser/light therapies, botulinum toxin A injections, facial lift, facial peels, excisional facial surgery, dermal photorejuvenation, oral or maxillofacial surgery, etc.) that may interfere with the treatment area or evaluation within 6 months before screening as determined by the Principal Investigator.
* The subject who received soft tissue augmentation at the treatment site at any time before screening as determined by the Principal Investigator.
* Subjects with a scar or skin lesion at the treatment site that may interfere with the judgment of the treatment effect.
* Subjects who participated in another clinical trial within 60 days before screening or plan to participate in another investigation during this study.
* Subjects who plan to receive other wrinkle improvement treatments in the face during this trial.
* Subjects who are otherwise determined by the investigator as ineligible for this study.

Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes